Reading List: Inflammation (363-506)

363.          Seshadri P, et al. “A randomized study comparing the effects of a low-carbohydrate diet and a conventional diet on lipoprotein subfractions and C-reactive protein levels in patients with severe obesity.” American Journal of Medicine, Volume 117, Issue 6, Pages 398-405. September 15, 2004.

364.          van Oss CJ. “Influence of Glucose Levels on the In Vitro Phagocytosis of Bacteria by Human Neutrophils.” Infection and Immunity, Volume 4, Number 1, Pages 54–59. July 1971.

365.          Thomas MC, et al. “Early peri-operative hyperglycaemia and renal allograft rejection in patients without diabetes.” Nephrology (BioMed Central). Volume 1, Number 1. 2000. Published online October 4, 2000.

366.          Yudkin JS, Stehouwer CDA, Emeis JJ and Coppack SW. “C-Reactive Protein in Healthy Subjects: Associations With Obesity, Insulin Resistance, and Endothelial Dysfunction. A Potential Role for Cytokines Originating From Adipose Tissue.” Arteriosclerosis, Thrombosis, and Vascular Biology, (the American Heart Association, Inc.) Volume 19, Number 4, Pages 972-978. 1999.

367.          Tishler M, et al. “Fibromyalgia in diabetes mellitus.” Rheumatology Inernational, Volume 23, Number 4, Pages 171-3. July 2003. Electronically published 2003 May 20.

368.          Sampson MJ, et al. “Monocyte and Neutrophil Adhesion Molecule Expression During Acute Hyperglycemia and After Antioxidant Treatment in Type 2 Diabetes and Control Patients.” Arteriosclerosis, Thrombosis, and Vascular Biology. Volume 22, Pages 1187-1193. July 2002.

369.          Scherrer U, et al. “Nitric oxide release accounts for insulin’s vascular effects in humans.” Journal of Clinical Investigation, Volume 94, Number 6, Pages 2511–2515. December 1994.

370.          Giugliano, D, et al. “Vascular Effects of Acute Hyperglycemia in Humans Are Reversed by L-Arginine. Evidence for Reduced Availability of Nitric Oxide During Hyperglycemia.” Circulation, of the American Heart Association, Volume 95, Number 7, Pages 1783-1790. 1997.

371.          Marfella R, et al. “Circulating Adhesion Molecules in Humans. Role of Hyperglycemia and Hyperinsulinemia.” Circulation, of the American Heart Association, Volume 101, Number 19, Pages 2247-2251. 2000.

372.          Marfella, R, et al. “ Acute hyperglycemia induces an oxidative stress in healthy subjects.” Journal of Clinical Investigation, Volume 108, Number 4, Pages 635–636. August 15, 2001.

373.          Esposito K, et al. “ Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans Role of Oxidative Stress.”Circulation, Published online Volume 106, Number 16, Pages 2067-2072. September 30, 2002,

374.          Adams TD, et al. “Long-Term Mortality after Gastric Bypass Surgery.” The New England Journal of Medicine. Volume 357, Number 8, Pages 753-761. August 23, 2007.

375.          Liu S, et al. “Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women.” American Journal Clinical Nutrition. Volume 75, Number 3, Pages 492–8. 2002.

376.          Chan AT, Ogino, S and Fuchs, CS. “Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of COX-2.” New England Journal Of Medicine, Volume Volume 356, Number 2, Pages 2131-2142. May 24, 2007.

377.          Persaud,SJ, Burns CJ, Belin VD and Jones PM. “Glucose-Induced Regulation of COX-2 Expression in Human Islets of Langerhans.”Diabetes. Volume 53, Supplement 1, Pages S190–S192, 2004.

378.          Terry MB, et al. “Association of Frequency and Duration of Aspirin Use and Hormone Receptor Status With Breast Cancer Risk.” Journal of American Medical Association. Volume 291 Number 20, Pages 2433-2440. May 26, 2004.

379.          Schottenfeld D and Beebe-Dimmer J. “Chronic Inflammation: A Common and Important Factor in the Pathogenesis of Neoplasia.” CA: A Cancer Journal for Clinicians. Volume 56, Number 2, Pages 69-83. March/April 2006.

380.          Shacter E and Weitzmen SA. “Chronic Inflammation and Cancer.”Oncology. 2002 Feb; Volume 16, Number 2), Pages 217-26, and 229. February 2002.

381.          National Cancer Institute. “Executive Summary of Inflammation and Cancer Think Tank.” Division of Cancer Biology.

382.          Kasim-Karakas SE, et al.. “Responses of inflammatory markers to a low-fat, high-carbohydrate diet: effects of energy intake.” American Journal of Clinical Nutrition, Volume 83, Number 4, Pages 774-779, April 2006.

383.          Gulam W and Ahsan H. “Reactive oxygen species: role in the development of cancer and various chronic conditions.” Journal of Carcinogenesis2006, Volume 5, Number 14. 2006.

384.          Kasum CM, Blair CK, Folsom AR and Ross JA. “Non-steroidal Anti-inflammatory Drug Use and Risk of Adult Leukemia.” Cancer Epidemiology, Biomarkers & Prevention. Volume 12, Pages 534–537, June 2003.

385.          Zhou XM, et al. “Non-steroidal anti-inflammatory drugs induce apoptosis in gastric cancer cells through up-regulation of bax and bak.”Carcinogenesis. Volume 22, Number 9, Pages 1393-1397, September 2001.

386.          Surh Y-J, Kundu JK, Na H-K and Lee J-S. “Redox-Sensitive Transcription Factors as Prime Targets for Chemoprevention with Anti-Inflammatory and Antioxidative Phytochemicals.” Journal of Nutrition. Volume 135, Supplement 12, Pages 2993S-3001S, December 2005.

387.          Kreeger K. Inflammation’s infamy: The body’s first line of defense just may be the ‘root of all evil.” The Scientist. Volume 17, Issue 14, Page 28. July 14, 2003.

388.          Liu E, et al. “Aspirin Use and Risk of Biliary Tract Cancer: A Population-Based Study in Shanghai, China.” Cancer Epidemiology, Biomarkers & Prevention. 2005 Volume 14, Number 5, Pages 1315-1318. May 2005.

389.          National Cancer Institute. ” Aspirin May Reduce Risk of Colon Polyps.”  Clinical Trial Results. Posted: 04/09/2002    Reviewed: 10/31/2005

390.          Rahme E. et al. “Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer.” BioMed Central Cancer. Volume 5, Number159. 2005.

391.          Chan AT, et al. “Long-term Use of Aspirin and Nonsteroidal Anti-inflammatory Drugs and Risk of Colorectal Cancer.” Journal of American Medical Association. Volume 294, Number 8, Page 914-923. August 24/31, 2005.

392.          Anderson LA, et al. “Nonsteroidal Anti-inflammatory Drugs and the Esophageal Inflammation-Metaplasia-Adenocarcinoma Sequence.” Cancer Research. Volume 66, Number 9, Pages 4975-4982, May 1, 2006.

393.          García Rodríguez LA. and Huerta-Alvarez C. “Reduced Risk of Colorectal Cancer among Long-Term Users of Aspirin and Nonaspirin Nonsteroidal Antiinflammatory Drugs.” Epidermiology. Volume 12, Number 1, Pages 88-93. January 2001.;jsessionid=H0bpGpH67TW2pg1YnKQtMw8qzV2pHnZGnQFXWqJ1rmckQDQq9pFs!1390229169!181195629!8091!-1?&fullimage=true

394.          Barsheshet A, et al. “Admission Blood Glucose Level and Mortality Among Hospitalized Nondiabetic Patients With Heart Failure.” Archives of Internal Medicine. Volume166, Number 15. Pages 1613-1619. August 14/28, 2006.

395.          Moysich KB, et al. “Regular aspirin use and lung cancer risk.” BioMed Central Cancer. Volume 2, Number 31. 2002.

396.          Wall RJ, Shyr Y and Smalley W. “Nonsteroidal Anti-Inflammatory Drugs and Lung Cancer Risk: A Population-Based Case Control Study.” Journal of Thoracic Oncology . Volume 2, Number 2, Pages 109-114. February 2007.

397.          National Cancer Institute. “Aspirin Use Is Not Associated with Pancreatic Cancer Mortality, Study Reports.” NCI Cancer Bulletin. Volume 1, Number 16. Page 4#b. April 20, 2004.

398.          National Cancer Institute. “Aspirin Protective Against Prostate Cancer, Study Suggests.” NCI Cancer Bulletin. Volume 1, Number 13, Page 6#a.. March 30, 2004

399.          National Cancer Institute. “Lower Breast Cancer Risk With Aspirin Linked to Hormone-Receptor Status.” NCI Cancer Bulletin. Volume 1, Number 21, May 25, 2004.

400.          Cotterchio M, et al.. “Nonsteroidal Anti-inflammatory Drug Use and Breast Cancer Risk.” Cancer Epidemiology Biomarkers & Prevention. Volume 10, Number 11, Pages 1213-1217, November 2001.

401.          National Cancer Institute. “Nonsteroidal Anti-Inflammatory Drugs and Cancer Prevention.” Surveilance Epidemiology and End Results.

402.          Baron JA, et al. “A Randomized Trial of Aspirin to Prevent Colorectal Adenomas.” New England Journal of Medicine. Volume 348, Number 10, Pages 891-899. March 6, 2003.

403.          Mohanty P, et al. “Glucose Challenge Stimulates Reactive Oxygen Species (ROS) Generation by Leucocytes.” Journal of Clinical Endocrinology & Metabolism .Volume 85, Number 8, Pages 2970-2973. 2000.

404.          Wellen, KE, et al. “nflammation, stress, and diabetes.” Journal of  Clinical Investigation. Volume 115, Number 5, Pages 1111–1119. May 2, 2005.

405.          Dandona P. et al. “Insulin infusion in acute illness.” Journal of  Clinical Investigation.. Volume 115, Number 8, Pages 2069–2072.  August 1, 2005.

406.          Hu Y, et al. “Relations of glycemic index and glycemic load with plasma oxidative stress markers.” American Journal of Clinical Nutrition, Volume 84, Number 1, 70-76, July 2006.

407.          Giugliano D, et al. “The Effects of Diet on Inflammation.” Journal of American  College of Cardiology. Volume 48, Number 4, Pages 677-685. 2006.

408.          Maggio M, et al.  “Circulating Inflammatory Cytokine Expression in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy.” Journal of Andrology. Volume 27, Number 6, November/December 2006.

409.          Dennis LK, et al. “Epidemiologic association between prostatitis and prostate cancer.” Urology. Volume 60, Number 1, Pages 78-83. July 2002.

410.          Platz EA, et al. “Epidemiology of Inflammation and Prostate Cancer.” The Journal of Urology. Volume 171, Issue 2 (supplement), Pages S36-S40, Feb. 2004.

411.          Nelson WG, et al. “The Role of Inflammation in The Pathogenesis of Prostate Cancer.” The Journal of Urology.  Volume 172, S6–S12, November 2004.

412.          MacLenman GT, et al. “The Influence of Chronic Inflammation in Prostatic Carcinogenesis: A 5-Year Followup Study.” Journal of Urology. Volume 176, Number 3, Pages 1012-1016. September 2006.

413.          Libby P, Ridker PM and Maseri A. “Inflammation and Atherosclerosis.”Circulation. Volume 105, Pages 1135-1143. 2002.

414.          Wang HW, et al. “Non-steroidal Anti-inflammatory Drug Use and the Risk of Gastric Cancer: A Systematic Review and Meta-analysis.” Journal of the National Cancer Institute, Volume. 95, Number. 23, December 3, 2003.

415.          Liu S, et al. “Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women” American Journal of Clinical Nutrition. Volume 75, Number 3, Pages 492–8.2002.

416.          Yu WK, et al. “Influence and mechanism of a tight control of blood glucose by intensive insulin therapy on human sepsis.” (Article in Chinese)Zhonghua Wai Ke Za Zhi. Volume 43, Number 1, Pages 29-32. January 1, 2005.…EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

417.          Seshadri P, et al. “A Randomized Study Comparing the Effects of a Low-Carbohydrate Diet and a Conventional Diet on Lipoprotein Subfractions and C-Reactive Protein Levels in Patients with Severe Obesity.” American Journal of Medicine. Volume 117, Pages 398–405. 2004.

418. Verma S, et al. “A Self-Fulfilling Prophecy: C-Reactive Protein Attenuates Nitric Oxide Production and Inhibits Angiogenesis.” Circulation. Volume 106, Number 8, Pages 913-919. August 20, 2002.

419.          Di Napoli M. “C-Reactive Protein and Acute Phase of Ischemic Stroke.”British Medical Journal. Volume 322, Number 302, Page 1605. June 30, 2001.

420.          King DE, et al. “C-Reactive Protein and Glycemic Control in Adults With Diabetes.” Diabetes Care. Volume 26, Number 5. Pages 1535–1539, 2003.

421.          Cao JJ, et al. “C-Reactive Protein, Carotid Intima-Media Thickness, and Incidence of Ischemic Stroke in the Elderly.” Circulation. Volume 108, Pages 166-170. 2003.

422.          Marfella  R, et al. “Clinical Investigation and Reports: Circulating Adhesion Molecules in Humans. Role of Hyperglycemia and Hyperinsulinemia.”Circulation. Volume101, Number 19, Pages 2247. 2000.

423.          Capuzzi DM and Freeman JS. “C-Reactive Protein and Cardiovascular Risk in the Metabolic Syndrome and Type 2 Diabetes: Controversy and Challenge.” Clinical Diabetes.  Volume 25, Number 1, Pages 16-22,. 2007.

424.          Dhindsa S, et al. “Differential effects of glucose and alcohol on reactive oxygen species generation and intranuclear nuclear factor-κB in mononuclear cells.” Metabolism. Volume 53, Issue 3, Pages 330-334. March 2004.

425.          Chapman HA. “Disorders of lung matrix remodeling.” Journal of Clinical Investigation. Volume 113, Number 2, Pages 148–157.  January 15, 2004.

426.          Ding X, et al. “Effects of simulated hyperglycemia, insulin, and glucagon on endothelial nitric oxide synthase expression.” American Journal of Physiology- Endocrinology and Metabolism. Volume 279, Issue 1, Pages E11-E17, July 2000.

427.          Zieske AW, et al. “Elevated Serum C-Reactive Protein Levels and Advanced Atherosclerosis in Youth.” Arteriosclerosis, Thrombosis, and Vascular Biology. Volume 25, Number 6, Pages 1237-1243. 2005.

428.          van Oss CJ. “Influence of Glucose Levels on the In Vitro Phagocytosis of Bacteria by Human Neutrophils.” INFECrION AND IMMUNITY. Volume 4, Number 1, Pages 54-59. July 1971.

429.          The Ohio State University Medical Center. “Hyperglycemia Linked to Hospital Mortality in AML Patients.” Press Release. June 4, 2007.

430.          Ceolotto G, et al. “Hyperglycemia Acutely Increases Monocyte Extracellular Signal-Regulated Kinase Activity in Vivo in Humans.” Journal of Clinical Endocrinology & Metabolism. Volume 86, Number 3, Pages 1301-1305. 2001.

431.          Basu A, et al. “Dietary Factors That Promote or Retard Inflammation.”Arteriosclerosis, Thrombosis, and Vascular Biology. Volume 26, Number 5, Pages 995-1001. February 16, 2006.

432.          Kempf K, et al. “Inflammation in Metabolic Syndrome and Type 2 Diabetes:Impact of Dietary Glucose.” Annals of the New York Academy of Science. Volume 1084, Number 1, Pages 30–48. November 2006.

433.          Nappo F, et al. “Postprandial Endothelial Activation in Healthy Subjects and in Type 2 Diabetic Patients: Role of Fat and Carbohydrate Meals.” Journal of the American College of Cardiology. Volume 39, Number 7, Pages 1145-1150. April 3, 2002.

434.          Blackburn P, et al. “Postprandial Variations of Plasma Inflammatory Markers in Abdominally Obese Men.” Obesity. Volume 14, Number 10, Pages 1747-1754. 2006.

435.          Hu Y, et al. “Relations of glycemic index and glycemic load with plasma oxidative stress markers.” American Journal of Clinical Nutrition, Volume 84, Number 1, Pages 70-76, July 2006.

436.          Esposito K, et al. “Stress Hyperglycemia, Inflammation, and Cardiovascular Events.” Diabetes Care.  Volume 26, Number 5, Pages 1650-1651. 2003.

437.          Dandona P, et al. “The Potential Therapeutic Role of Insulin in Acute Myocardial Infarction in Patients Admitted to Intensive Care and in Those With Unspecified Hyperglycemia.” Diabetes Care. Volume 26, Number 2, Pages 516-519. 2003.

438.          Dahl M, et al. “C-reactive Protein as a Predictor of Prognosis in Chronic Obstructive Pulmonary Disease.” American Journal of Respiratory and Critical Care Medicine. Volume 175, Number 3, Pages 250-255. 2007.

439.          Verma S, et al. “Hyperglycemia potentiates the proatherogenic effects of C-reactive protein: reversal with rosiglitazone.” Journal of Molecular and Cellular Cardiology. Volume 35, Issue 4, Pages 417-419. April 2003.

440.          Fukuhara M, et al. “Hyperglycemia Promotes Microinflammation as Evaluated by C- Reactive Protein in the Very Elderly.” Internal Medicine. (Japanese) Volume 46, Number 5, Pages 207-212.  2007.

441.          Noyman I, et al. “Hyperglycemia reduces nitric oxide synthase and glycogen synthase activity in endothelial cells.” Nitric Oxide. Volume 7, Number 3, Pages 187-93. November 2002.

442.          Dauphine C, et al. “Identification of Admission Values Predictive of Complicated Acute Alcoholic Pancreatitis.” Archives of Surgery. Volume 139, Number 9, Pages 978-982. September 2004.

443.          Pauletto P and Rattazzi M. “Inflammation and hypertension: the search for a link.” Nephrology Dialysis Transplantation. Volume 21, Number 4, Pages 850-853. 2006.

444.          Savoia C and Schffrin EL.” Inflammation in hypertension.” Current Opinion in Nephrology and Hypertension. Volume15, Number 2, Pages 152-8. March 2006.

445.          Engström G, et al. “Inflammation-Sensitive Plasma Proteins, Diabetes, and Mortality and Incidence of Myocardial Infarction and Stroke.” Diabetes. Volume 52, Number 2, Pages 442-447. 2003.

446.          Ridker PM, et al. “Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men.” New England Journal of Medicine. Volume 336, Number 14, Pages 973-979. April 3, 1997.

447. Wellen KE and Hotamisligil GS. “Inflammation, stress, and diabetes.”Journal of  Clinical Investigation. Volume 115, Number 5, Pages1111–1119. May 2, 2005.

448.          Licastro F, et al. “Innate immunity and inflammation in ageing: a key for understanding age-related diseases.” Immunity and Ageing. Volume 2, Number 8. May 2005.

449.          The Diabetes Prevention Program Research Group. “Intensive Lifestyle Intervention or Metformin on Inflammation and Coagulation in Participants With Impaired Glucose Tolerance.” Diabetes. Volume 54, Number 5, Pages 1566-1572. May 2005.

450.          Morishita R. “Editorial: Is Vascular Endothelial Growth Factor a Missing Link Between Hypertension and Inflammation?” Hypertension. Volume 44, Number 3, Page 253-254. 2004.

451.          Boos CJ and Lip GYH. “Elevated high-sensitive C-reactive protein, large arterial stiffness and atherosclerosis: a relationship between inflammation and hypertension?” Journal of Human Hypertension. Volume 19, Number 7, Pages 511–513. 2005.

452.          Asadollahi K et al. “Laboratory risk factors for hospital mortality in acutely admitted patients.” QJM. Volume 100, Number 8, Pages 501-7. August 2007.

453.          Morigi M, et al. “Leukocyte-endothelial Interaction Is Augmented by High Glucose Concentrations and Hyperglycemia in a NF-kB–dependent Fashion.” Journal of  Clinical Investigation. Volume 101, Number 9, Pages 1905–1915. May 1998.

454. Visser M, et al. “Low-Grade Systemic Inflammation in Overweight Children.”PEDIATRICS. Volume 107, Number 1, Pages e13-e18 January 2001.

455.          Korhonen R, et al. “Nitric oxide production and signaling in inflammation.”Current Drug Targets. Inflammation and Allergy. Volume 4, Number 4, Pages 471-9. August 2005.

456.          Tuttle HA, et al. “Platelet-neutrophil conjugate formation is increased in diabetic women with cardiovascular disease.” Cardiovascular Diabetology. 2003; Volume 2, Number 12. October 4, 2003.

457.          Altman R. “Risk factors in coronary atherosclerosis athero-inflammation: the meeting point.” Thrombosis Journal. Volume 1, Number 4. 2003.

458.          Seshadri P, et al. “A Randomized Study Comparing the Effects of a Low-Carbohydrate Diet and a Conventional Diet on Lipoprotein Subfractions and C-Reactive Protein Levels in Patients with Severe Obesity.” American Journal of Medicine. Volume 117, Pages 398–405. 2004.

459.          Li X, et al. “Systemic Diseases Caused by Oral Infection.” Clinical Microbiology Reviews. Volume 13, Number 4, Pages 547–558. October 2000.

460.          Anderson MM, et al. “The myeloperoxidase system of human phagocytes generates Ne-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation.”Journal of Clinical Investigation. Volume 104, Number 1, Pages 103–113. July 1, 1999.

461.          Pepys MB and Berger A. “Editorials: The renaissance of C- reactive protein.” British Medical Journal. Volume 322, Number 7277, Pages 4-5. January 6, 2001.

462.          Savoia C and Schffrin EL “Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions..” Clinical Science. (London) Volume 112, Number 7, Pages 375-84. June 2007.

463.          Chen H, et al. “Nonsteroidal Anti-inflammatory Drugs and the Risk of Parkinson Disease.” Archives of Neurology. Volume 60, Number 8, Pages 1059-1064. August 2003.

464.          Buczkowska EO. “Alterations of blood glucose homeostasis during septic or injury stress—hyperglycemia.” Wiadomości lekarskie. Volume 55, Number 11-12, Pages 731-44. 2002.

465. Martino G, et al. “Inflammation in multiple sclerosis: the good, the bad, and the complex.” The Lancet Neurology. Volume 1, Number 8. December 1, 2002.

466.          Orr AA. “Inflammation is key to ALS.” From the Laboratories. Volume 2, Issue 7. July 2003.

467. Riley CF, et al. “Inflammatory markers in endometriosis: reduced peritoneal neutrophil response in minimal endometriosis.” Acta Obstetricia et Gynecologica Scandinavica. Volume 86, Number 7, Pages 877-81. 2007.

468. Agic A, et al. “Is endometriosis associated with systemic subclinical inflammation?” Gynecologic and Obstetric Investigation. Volume 62, Number 3, Pages 139-47. 2006.

469.          Videm V, et al. “Multiple inflammatory markers in patients with significant coronary artery disease.” International Journal of  Cardiology. Volume118, Number 1, Pages 81-7. May 16, 2007.

470.          Orio F, et al. “The Increase of Leukocytes as a New Putative Marker of Low-Grade Chronic Inflammation and Early Cardiovascular Risk in Polycystic Ovary Syndrome.” Journal of Clinical Endocrinology & Metabolism. Volume 90, Number 1, Pages 2–5. 2005.

471.          Ness R and Cottreau C. “Possible Role of Ovarian Epithelial Inflammation in Ovarian Cancer.” Journal of the National Cancer Institute. Volume 91, Number 17, Pages 1459-1467. 1999.

472.          Van den Berghe G. “How does blood glucose control with insulin save lives in intensive care?” Journal of Clinical Investigation, Volume 114, Number 9, Pages 1187–1195. November 1, 2004.

473.          Desroches S, et al. “Baseline Plasma C-Reactive Protein Concentrations Influence Lipid and Lipoprotein Responses to Low-Fat and High Monounsaturated Fatty Acid Diets in Healthy Men.” Journal of Nutrition. Volume 136, Number 4, Pages 1005–1011. 2006.

474.          de Rekeneire N, et al. “Diabetes, Hyperglycemia, and inflammation in Older Individuals. The Health, Aging and Body Composition study.” Diabetes Care. Volume 29, Number 8, Pages 1902-1908. 2006.

475.          Manning PJ, et al. “Changes in Circulating Postprandial Proinflammatory Cytokine Concentrations in Diet-Controlled Type 2 Diabetes and the Effect of Ingested Fat.” Diabetes Care. Volume 27, Number 10, Pages 2509-2511. 2004.

476.          Platts-Mills TAE. “Asthma Severity and Prevalence: An Ongoing Interaction between Exposure, Hygiene, and Lifstyle.” PLoS Medicine. Volume 2, Number 2, Pages e34. February 2005.

477.          Nickoloff1 BJ and Nestle FO. “Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities.”Journal of Clinical Investigation. Volume 113, Number 12, Pages 1664–1675. June 15, 2004.

478.          Perticone F, et al. “Endothelial Dysfunction and Mild Renal Insufficiency in Essential Hypertension.” Circulation.  Published online Aug 2, 2004.

479.          Hotamisligil GS, et al. “Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.” Journal of Clinical Investigation, Volume 95, Number 5, Pages 2409–2415. May 1995.

480.          Miyazaki Y, et al. “Tumor necrosis factor and insulin resistance in obese ype 2 diabetic patients.” International Journal of Obesity. (2003) Volume 27, Pages 88–94. 2003.

481.          The Diabetes Prevention Program Research Group. “Intensive Lifestyle Intervention or Metformin on Inflammation and Coagulation in Participants With Impaired Glucose Tolerance.” Diabetes. Volume 54, Number 5, Pages 1566–1572. May 2005. .

482.          Jayaprakash V, et al. “Chemoprevention of Head and Neck Cancer With Aspirin.” Archives of Otolaryngology-Head & Neck Surgery. Volume 132, Number 11, Pages 1231-1236. 2006.

483. Wright, Jr. E, et al. “Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia.” International Journal of Clinical Practice. Volume 60, Number 3, Pages 308–314. March 2006.

484.          Osawa T and Kato Y. “Protective Role of Antioxidative Food Factors in Oxidative Stress Caused by Hyperglycemia.” Annals of the New York Academy of Science. Volume 1043, Number 1, Pages 440–451. June 2005.

485.          Hong, S, et al. “Detection of viral infections in prostate tumor tissues associated with RNase L variant R462Q.”

486.          Don BR and Kaysen G. “Serum albumin: relationship to inflammation and nutrition.” Seminars in Dialysis. Volume 17, Number 6, Pages 432-7. 2004 November-December 2004.

487.          Desai MY. Et al. “Association of Body Mass Index, Metabolic Syndrome, and Leukocyte Count.” American Journal of Cardiology. Volume 97, Issue 6, Pages 835-838. March 15, 2006,

488.          Danesh J, et al. “Association of Fibrinogen, C-reactive Protein, Albumin, or Leukocyte Count With Coronary Heart Disease.” Journal of American Medical Association.  Volume 279, Pages 1477-1482. 1998.

489.          Shankar A, et al. “The association between circulating white blood cell count, triglyceride level and cardiovascular and all-cause mortality: Population-based cohort study.” Atherosclerosis. Volume 192, Issue 1, Pages 177-183. May 2007.

490.          Yoon SS and Zheng Z-J. “Elevated total white blood cell count with high blood glucose is associated with poor outcome after ischemic stroke.”Journal of Stroke and Cerebrovascular Diseases. Volume 14, Issue 2, Pages 88-93. March-April 2005.

491.          Elkind MS, et al. “Elevated White Blood Cell Count and Carotid Plaque Thickness: The Northern Manhattan Stroke Study.” Stroke. Volume 32, Number 4, Pages 842-849. 2001.

492.          Ohshita K, et al. “Elevated White Blood Cell Count in Subjects With Impaired Glucose Tolerance.” Diabetes Care. Volume 27, Number 2, Pages 491-496. 2004.

493.          Kimura K, et al. “Hyperglycemia independently increases the risk of early death in acute spontaneous intracerebral hemorrhage.” Journal of the Neurological Sciences. Volume 255, Issues 1-2, Pages 90-94. April 15, 2007,

494.          Margolis KL, et al. “Leukocyte Count as a Predictor of Cardiovascular Events and Mortality in Postmenopausal Women. The Women’s Health Initiative Observational Study.” Archives of Internal Medicine. Volume 165, Number 5, Pages 500-508. 2005.

495.          Chung F-M, et al. “Peripheral Total and Differential Leukocyte Count in Diabetic Nephropathy. The relationship of plasma leptin to leukocytosis.”Diabetes Care. Volume 28, Number 5, Pages 1710-1717, 2005.

496.          Phillips AN, et al. “The Leukocyte Count and Risk of Lung Cancer.” Cancer. Volume 69, Issue 3, Pages 680-684. 1992.

497.          Tamakoshi K, et al. “U-Shaped Association Between White Blood Cell Count and Fasting Plasma Glucose Level.” Diabetes Care. Volume 26, Number 3, Page 950, 2003.

498.          Remzi M and Djavan B. “New Findings in Prostate Cancer, Benign Prostatic Hyperplasia, and Sexual Dysfunction.” Reviews in Urology. Volume 6, Number 1, Pages 19–28. Winter 2004.

499.          Dennis LK and Dawson DV. “Meta-Analysis of Measures of Sexual Activity and Prostate Cancer.”  Epidemiology. Volume 13, Number 1, Pages 72-9. January 2002.

500. Solga S, et al. “Dietary Composition and Nonalcoholic Fatty Liver Disease.”Digestive Diseases and Science. Volume 49, Number 10, Pages 1578-1583. October, 2004.

501. Capes SE, et al. “Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic Patients. A Systematic Overview.” Stroke. Volume 32, Pages 2426-2432. 2001.

502.          Webster KA. “Stress hyperglycemia and enhanced sensitivity to myocardial infarction.” Current Hypertension Reports. Volume 10, Number 1, Pages 78-84. February 2008.

503.          Madjid M, et al. “Leukocyte count and coronary heart disease. Implications for risk assessment.” Journal of the American College of Cardiology. Volume 44, Number 10, Pages 1945–56.  2004.

504.          Ratliff JC, et al. “Eggs modulate the inflammatory response to carbohydrate restricted diets in overweight men.” Nutrition & Metabolism. Volume 5, Number 6. March 2008.

505.          Rao KV, et al. “Keloid and diabetes in a family.” The Journal of the Association of Physicians of India. Volume 38, Number 8, Page 585. 1990.

506.          Alexander G, et al. “Clinical Genetics of Familial Keloids.” Archives of Dermatology. Volume 137, Number 11, Pages 1429-1434. November 2001.

Previous | Study Guide | Next